Goldstein covers the Healthcare sector, focusing on stocks such as Corvus Pharmaceuticals, CytomX Therapeutics, and Fate Therapeutics. Currently, the analyst consensus on Merck & Company is a Strong …
More Merck & Company (MRK) Gets a Buy Rating from Mizuho Securities Videos